Process for the preparation of a diarylthiohydantoin compound

作者: Andras Horvath , Cyril Ben Haim , Johan Erwin Edmond Weerts

DOI:

关键词: Combinatorial chemistryProstate cancerScientific methodChemistry

摘要: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated treatment prostate cancer.

参考文章(8)
Ashok Malavalli, Scott D. Olsen, Kim D. Vandegriff, Diaspirin crosslinked pegylated hemoglobin ,(2013)
Alexandre V. Ivachtchenko, Yan A. Ivanenkov, Oleg D. Mitkin, Anton A. Vorobiev, Irina V. Kuznetsova, Natalia A. Shevkun, Angela G. Koryakova, Ruben N. Karapetian, Andrey S. Trifelenkov, Dmitry V. Kravchenko, Mark S. Veselov, Nina V. Chufarova, Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonists European Journal of Medicinal Chemistry. ,vol. 99, pp. 51- 66 ,(2015) , 10.1016/J.EJMECH.2015.05.039
Ouathek Ouerfelli, Hong Zhao, Guangbin Yang, Anna Dilhas, Synthesis of thiohydantoins ,(2008)
Nicholas D. Smith, Celine Bonnefous, Jackaline D. Julien, Androgen receptor modulators and uses thereof ,(2011)
Samedy Ouk, Chris Tran, Michael E Jung, John Wongvipat, Charles L Sawyers, Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases ,(2007)
Richard A. Rampulla, Toomas Mitt, Sören Giese, Aberra Fura, Ronald L. Hanson, Ramesh N. Patel, Mark E. Salvati, Dacia A. Pickering, Hai-Yun Xiao, James R. Corte, James Aaron Balog, Jacques Y. Roberge, Raj N. Misra, Steven H. Spergel, Wenying Li, Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function ,(2002)